CA Patent

CA2813472A1 — Rapid solidifying crystalline-amorphous inks

Assigned to Xerox Corp · Expires 2013-10-26 · 13y expired

What this patent protects

A phase change ink composition comprising an amorphous compound and a crystalline compound capable of crystallizing at a total crystallization time of less than 15 seconds and methods of making the same.

USPTO Abstract

A phase change ink composition comprising an amorphous compound and a crystalline compound capable of crystallizing at a total crystallization time of less than 15 seconds and methods of making the same.

Drugs covered by this patent

Patent Metadata

Patent number: CA2813472A1
Jurisdiction: CA
Classification: —
Expires: 2013-10-26
Drug substance claim: No
Drug product claim: No
Assignee: Xerox Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.